Sign Up to like & get
recommendations!
1
Published in 2018 at "Psychopharmacology"
DOI: 10.1007/s00213-018-5081-7
Abstract: IntroductionThe uncompetitive N-methyl-D-aspartate (NMDA) receptor (NMDAR) antagonist ketamine has been proposed to model symptoms of psychosis. Inhibitory deficits in the schizophrenia spectrum have been reliably reported using the antisaccade task. Interestingly, although similar antisaccade deficits…
read more here.
Keywords:
effects ketamine;
ketamine;
ketamine brain;
brain function ... See more keywords